IL1B and familial Mediterranean fever: Considering the role of specific cytokines in the pathogenesis of FMF, clinicians are increasingly turning to biologic agents targeting IL-1, IL-6, TNF-α, and JAK pathways when colchicine treatment is ineffective or intolerable2.